Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells

World Journal of Gastroenterology

Volumn 15, Issue 36, 2009, Pages 4582-4586

  Xiao, En Hua ^a   Guo, Dong ^a   Bian, Du Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Immunohistochemistry; Transcatheter arterial chemoembolization; Vascular endothelial growth factor

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CD31 ANTIGEN; GELATIN SPONGE; IODINATED POPPYSEED OIL; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CARCINOMA CELL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PROTEIN EXPRESSION; SURGICAL TECHNIQUE;

ADULT; AGED; ANTIGENS, CD31; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION, PERIPHERAL; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREOPERATIVE CARE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 71749102857     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.4582     Document Type: Article

References (30)

1. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19: 3-23 (Pubitemid 40331495)
2. Ramsey WH, Wu GY. Hepatocellular carcinoma: update on diagnosis and treatment. Dig Dis 1995; 13: 81-91
3. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang BH, Lin ZY, Lu JZ, Liu KD, Fan Z, Zeng ZC. Treatment of unresectable primary liver cancer: with reference to cytoreduction and sequential resection. World J Surg 1995; 19: 47-52
4. Cai J, Hu J, Che X, Zhao J, Bi X, Shao Y. Prognosis of primary liver carcinoma treated with local resection. Chin Med J (Engl) 2003; 116: 187-190 (Pubitemid 36504043)
5. Ezaki T, Koyanagi N, Yamagata M, Kajiyama K, Maeda T, Sugimachi K. Postoperative recurrence of solitary small hepatocellular carcinoma. J Surg Oncol 1996; 62: 115-122 (Pubitemid 26196508)
6. Xie WF, Cai HP. Research progress of primary liver cancer. Zhongguo Shiyong Neike Zazhi 2006; 26: 1931-1933
7. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442 (Pubitemid 36152543)
8. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171 (Pubitemid 34454013)
9. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224: 47-54 (Pubitemid 34680374)
10. Xiao E, Li D, Shen S, Zhou S, Tan L, Wang Y, Luo J, Wu Y, Tan C, Liu H, Zhu H. Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells. Chin Med J (Engl) 2003; 116: 203-207 (Pubitemid 36504047)
11. Xiao EH, Hu GD, Li JQ, Huang JF. Trans catheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma. Zhonghua Zhongliu Zazhi 2005; 27: 478-482
12. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000; 88: 1574-1581 (Pubitemid 30183142)
13. Xiao EH, Li JQ, Huang JF. Ef fec t of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells. World J Gastroenterol 2007; 13: 4509-4513 (Pubitemid 47412417)
14. Xiao EH, Hu GD, Li JQ. The effect of preoperative transcatheter arterial chemoembolization on prognosis of patients with hepatocellular carcinoma in different sizes. Zhonghua Fangshexue Zazhi 2001: 35: 598
15. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31
16. Li XM, Tang ZY, Zhou G, Lui YK, Ye SL. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res 1998; 17: 13-17 (Pubitemid 28215959)
17. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169-180
18. Park YN, Kim YB, Yang KM, Park C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 2000; 124: 1061-1065 (Pubitemid 30602050)
19. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D. Vascular endothelial growth factor upregulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 1997; 57: 5421-5425 (Pubitemid 27516384)
20. Xu H, Wang B, Gao ZQ, Yu DX, Cao GW, Sun YG. Effects of hepatic arterial chemo-embolization of hepatocellular carcinoma on tumor angiogenesis. Shiyong Fangshexue Zazhi 2004; 20: 620-622
21. Wang B, Xu H, Cao GW, Sun YG, Yu DX, Ni HF. Effects of hepatic arterial chemo-embolization of hepatocellular carcinoma on tumor angiogenesis and vascular endothelial growth factor expression. Zhonghua Fangshexue Zazhi 2005; 39: 204-206
22. Shao GL, Wang JH, Zhou KR. Study of embolization microvessel density and vascular endothelial growth factor expression of HCC residual tumor after chemoembolization. Zhonghua Ganzangbing Zazhi 2002; 10 : 170-173
23. Li X, Feng GS, Zheng CS. Experimental study of effect of TACE on tumor angiogenesis. Zhonghua Fangshexue Zazhi 2002; 36: 689-693
24. Liao XF, Yi JL, Yang ZF. Changes of tumor microvessel density of hepatocellular carcinoma after chemoembolization. Huazhong Keji Daxue Xuebao (Yixueban) 2002; 31: 544-546
25. Xiang XT, Liu ZW, Shi XJ. Expressions of microvascular density and vascular endothelial growth factor of liver cancer after transcatheter hepatic artery chemoembolization. Jiefangjun Yixue Zazhi 2005; 30: 45
26. Liao XF, Yi JL, Zhang WJ. Changes of tumor angiogenesis of rabbit liver cancer after the hepatic artery embolization. Zhonghua Shiyan Waike Zazhi 2004; 21: 1173-1175
27. Guo WJ, Li J, Chen Z, Zhuang JY, Gu WH, Zhang L, Pang J, Lu CH, Zhang WZ, Cheng YF. Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion. Hepatogastroenterology 2004; 51: 381-386 (Pubitemid 38445280)
28. Xiong ZP, Yang SR, Liang ZY, Xiao EH, Yu XP, Zhou SK, Zhang ZS. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemo embolization in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2004; 3: 386-390 (Pubitemid 39173071)
29. Makino Y, Uenishi R, Okamoto K, Isoe T, Hosono O, Tanaka H, Kanopka A, Poellinger L, Haneda M, Morimoto C. Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1- mediated signaling in hypoxic cells. J Biol Chem 2007; 282: 14073-14082 (Pubitemid 47100468)
30. Zhang ZJ, Wu MC, Liu Q. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Zhonghua Zhongliu Zazhi 1999; 21: 214-216 (Pubitemid 29291295)